GLP-1 pills are coming, and they could revolutionize weight-loss
WEB4 days ago · CNN —. Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before ...
Lasker awardee Svetlana Mojsov describes a yearlong journey out …
WEB2 days ago · After a whirlwind of new recognition for her GLP-1 research, the chemist has thoughts on allocating credit in science. Chemist Svetlana Mojsov made key discoveries involving the glucagon-like peptide-1 receptor in the 1980s. Lori Chertoff/Rockefeller University. The Lasker Awards, announced today, are among the most prestigious prizes in ...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
WEBJune 23, 2024, 5:46 PM UTC. By Berkeley Lovelace Jr. The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo...
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
WEB2 days ago · 215.13 KB. The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
WEBMay 21, 2024 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
WEBAug 12, 2024 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
WEBOct 30, 2023 · Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
FDA approves first oral GLP-1 treatment for type 2 diabetes
WEBThe U.S. Food and Drug Administration today approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise.
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEBThe FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight.
Research shows GLP-1 drugs are effective but complex
WEBMay 30, 2024 · While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment.
- Some results have been removed